The effects of aerobic exercise training at two different intensities in obesity and type 2 diabetes: implications for oxidative stress, low-grade inflammation and nitric oxide production by Krause, Mauricio et al.
Title: The effects of aerobic exercise training at two different intensities in obesity and type 2 1 
diabetes: Implications for oxidative stress, low grade inflammation and nitric oxide 2 
production 3 
 4 
Authors: Mauricio Krause
1, 2*
; Josianne Rodrigues-Krause
1
; Ciara O’Hagan2,3,; Paul 5 
Medlow
4
; Gareth Davison; Davide Susta
5
; Colin Boreham
2
; Philip Newsholme
6
; Mark 6 
O'Donnell
7
; Colin Murphy
1
 and Giuseppe De_Vito 
2, * 
7 
 8 
Authors Affiliations: 
1
Biomedical Research Group, Department of Science, Institute of 9 
Technology Tallaght, Dublin, Ireland; 
2
Institute for Sport and Health, University College 10 
Dublin, Dublin, Ireland; 
3
Academy of Sport and Physical Activity, Sheffield Hallam 11 
University, Sheffield, United Kingdom; 
4
Sport and Exercise Sciences Research Institute, 12 
University of Ulster, Jordanstown, Co Antrim, Northern Ireland, UK; 
5
Dublin City 13 
University, Dublin, Ireland and 
6
School of Biomedical Sciences, CHIRI Biosciences and 14 
Faculty of Health Sciences, Curtin University, Perth, Western Australia 6845; 
7
Department of 15 
Vascular and Endovascular Surgery, Royal Victoria Hospital, Belfast, Northern Ireland, UK.
 16 
Short Title: Exercise training responses in T2DM: Low vs. Moderate intensities 17 
Keywords: diabetes, obesity, adipokines, oxidative stress, nitric oxide, blood, skeletal muscle 18 
List of Abbreviations: GSH (Reduced Glutathione); GSSG (Glutathione Disulfide); tNOx 19 
(nitric oxide metabolites); T2DM (type 2 diabetes mellitus); CRP (C-reactive protein). 20 
Abstract word count: 250 Main text word count: 4454  N references: 49 21 
Number of Figures:  2 Number of Tables: 2 22 
 23 
Correspondence Address: Mauricio Krause, Institute of Technology Tallaght, Tallaght, 24 
Dublin 24, Dublin-Ireland and University College Dublin, Dublin 4, Dublin-Ireland. E-mail 25 
Address: mauriciokrause@hotmail.com 26 
ABSTRACT 27 
Aims: To investigate the effect of 16 weeks of aerobic training performed at two different 28 
intensities on nitric oxide (tNOx) availability and iNOS/nNOS expression, oxidative stress 29 
(OS) and inflammation in obese humans with or without Type 2 Diabetes Mellitus (T2DM). 30 
Methods: Twenty-five sedentary, obese (BMI 30kg/m2) males (52.87.2 yrs); 12 controls 31 
vs. 13 T2DM were randomly allocated to four groups that exercised for 30 minutes, three 32 
times per week either at low (Fat-Max; 30-40% VO2max) or moderate (Tvent; 55-65% 33 
VO2max) intensity. Before and after training, blood and muscle samples (v. lateralis) were 34 
collected. Results: Baseline erythrocyte glutathione was lower (21.82.8 vs. 32.74.4 35 
nmol/mL) and plasma protein oxidative damage and IL-6 were higher in T2DM (141.752.1 36 
vs. 75.541.6 nmol/mL). Plasma catalase increased in T2DM after Tvent training (from 37 
0.980.22 to 1.960.3 nmol/min/ml). T2DM groups demonstrated evidence of oxidative 38 
damage in response to training (elevated protein-carbonyls). Baseline serum tNOx were 39 
higher in controls than T2DM (18.682.78 vs. 12.343.56 mol/L). Training at Tvent 40 
increased muscle nNOS and tNOx in the control group only. Pre-training muscle nNOS was 41 
higher in controls than in T2DMs, while the opposite was found for iNOS. No differences 42 
were found after training for plasma inflammatory markers. Conclusion: Exercise training 43 
did not change body composition or aerobic fitness, but improved OS markers, especially 44 
when performed at Tvent. Non-diabetics responded to Tvent training by increasing muscle 45 
nNOS expression and tNOx levels in skeletal muscle while these parameters did not change 46 
in T2DM, perhaps due to higher insulin resistance (unchanged after intervention). 47 
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Introduction 58 
The World Health Organization (WHO) states that being overweight or obese is the 59 
fifth leading risk factor for global mortality (James 2008). Low-grade inflammation is a 60 
feature of both obesity and type 2 diabetes mellitus (T2DM) (Degens 2010; Krause et al. 61 
2012a), which are characterized by a chronic pro-inflammatory state associated with an 62 
increased release of key pro-inflammatory cytokines, e.g. tumor necrosis factor alpha (TNF-63 
) from different sources (Degens 2010; Krause et al. 2012a). TNF- signalling also induces 64 
activation of several pathways which initiate the production of free radicals, reactive oxygen 65 
species (ROS) and reactive nitrogen species (RNS) (Newsholme and Krause 2012), which 66 
promote impairment of insulin signalling (Newsholme and Krause 2012). 67 
Disrupted redox signalling or elevated oxidative stress (from prolonged periods of 68 
hyperglycaemia and/or  elevated pro-inflammatory cytokines) is thought to underlie the 69 
vascular dysfunction observed in individuals with glucose intolerance and diabetes 70 
(Cersosimo and DeFronzo 2006). Likewise, it has been shown that individuals with T2DM 71 
have more pronounced systemic inflammation and oxidative stress than those with normal 72 
glucose tolerance, leading to decreased bioavailability of nitric oxide (a key mediator of 73 
vessel tone, glucose uptake and -cell function) (Krause et al. 2012b; Krause et al. 2011; 74 
Newsholme et al. 2009; Newsholme et al. 2012). 75 
Regular moderate intensity aerobic exercise is widely recommended for sedentary 76 
individuals due to its beneficial effect on insulin sensitivity and glycaemic control (Boule et 77 
al. 2001). It is also known that such exercise can improve glycaemic and lipid  control in 78 
diabetes and consequently, reduce cardiovascular disease (CVD) risk factors through  79 
improvements in fasting blood lipids, postprandial glycaemia and lipaemia, blood pressure 80 
and body mass (Duncan 2006; Harding 2006). However, it is unclear which type, frequency 81 
and intensity  of exercise will be of most benefit for obese and/or T2DM individuals (Thomas 82 
et al. 2006). Previous work has reported a reduced capacity for fat oxidation, a shift from fat 83 
to carbohydrate utilisation at lower intensities during exercise and a lower exercise intensity 84 
associated with the maximal rate of fat oxidation in people with T2DM relative to healthy 85 
controls (Boon et al. 2007; Brun et al. 2007; Ghanassia et al. 2006). These findings have 86 
contributed to the promotion of low intensity aerobic exercise training (at the intensity 87 
corresponding to maximal rate of fat oxidation - “Fat-Max training”) so as to increase fat 88 
oxidation capacity (Brun et al. 2007), rather than moderate intensity training prescriptions 89 
(corresponding to either 60-70% of VO2max (Boon et al. 2007) or based on ventilatory 90 
thresholds (Tvent; (Belli et al. 2007; Fujita et al. 1990). While fat oxidation may be elevated 91 
under this intensity of exercise, information on the impact on other parameters of metabolic 92 
status or oxidative stress in T2DM patients is lacking. 93 
Therefore, the aim of this study was to investigate changes in nitric oxide availability 94 
(and iNOS/nNOS expression), oxidative stress and inflammatory markers in response to 95 
exercise training at two different intensities (Fat-Max vs. Tvent intensities) in obese males 96 
with and without T2DM. Specifically, we analyzed cytokines and adipokines that are known 97 
to modulate the availability of NO˙ and also be involved in the development of insulin 98 
resistance. 99 
 100 
Research Design and Methods 101 
Participants Characteristics 102 
Twenty-five sedentary (not engaged in any regular physical activity for the last six 103 
months) non-smoking male participants (52.87.2 years old), with body mass index (BMI) 104 
>27 kg/m
2
 volunteered for this study (12 obese controls vs. 13 obese T2DM, previously 105 
diagnosed by their personal physicians). BMI ranged from 27.05 to 38.08 kg/m
2
 for control 106 
subjects and 27.3 to 37.5 kg/m
2 
for T2DM. Informed consent was obtained from all 107 
volunteers prior to the study. Research assessments and protocols were approved by the UCD 108 
Dublin Human Research Ethics Committee. Participants were free from secondary 109 
complications of diabetes at the time of recruitment.  110 
 111 
Experimental Design 112 
Participants were recruited via advertising in local newspapers and workplaces. 113 
Participants attended the university laboratory for testing on five occasions. In session one, 114 
body composition was measured and a submaximal incremental treadmill test was performed 115 
to estimate aerobic capacity (VO2max) and to measure ventilatory threshold. Total body 116 
composition was assessed using dual energy X-ray absorptiometry (DEXA - Lunar iDXA, 117 
GE Healthcare, Buckinghamshire, United Kingdom). In session two, performed one week 118 
later, resting blood and skeletal muscle biopsy samples were taken following an overnight 119 
fast. The participants then completed a six-minute constant load exercise bout at an intensity 120 
corresponding to 35% estimated VO2max, followed by a second six-minute bout at an intensity 121 
corresponding to 25% estimated VO2max. The format of session three which was performed 122 
one week later was identical to session two, except for the intensity of the 2 six-minute 123 
constant load exercise bouts which corresponded to 60% and 45% of estimated VO2max 124 
respectively. Participants were then randomly assigned to train (not supervised) at either low 125 
(Fat-Max training) or moderate intensity (Tvent training), giving four groups: Obese Control 126 
training at Fat-Max (Control Fat-Max); Obese Diabetic training at Fat-Max (T2DM Fat-127 
Max); Obese Control training at Tvent (Control Tvent) and Obese Diabetic training at Tvent 128 
(Control Tvent). 129 
The unsupervised training programme (16 weeks) consisted of a continuous outdoor 130 
30 min walking, 3 times per week. Participants were provided with a heart rate (HR) monitor 131 
(Polar RS400) with their individual zone of training pre-programmed. Midway (week 8) 132 
through the training programme, participants returned to the laboratory (session four) and 133 
completed both the incremental and four submaximal constant load exercise bouts, for 134 
adjustment of their target HR training zone. Finally, after completing the 16 week 135 
programme, participants attended the laboratory for a fifth testing session, during which 136 
resting fasted blood and muscle samples were obtained and the exercise and body 137 
composition tests were repeated. The experimental design is described in Figure 1. 138 
 139 
Estimated aerobic power (VO2max) 140 
Maximal oxygen consumption (VO2max) was estimated from a sub-maximal 141 
incremental walking test. Briefly, participants walked on a motor driven treadmill (Venus 142 
200, HP Cosmos, Nussdorf-Traunstein, Germany) with a protocol of simultaneous changes in 143 
speed and slope, designed to achieve a linear increase in workload (Porszasz et al. 2003).  144 
The specific increments were calculated for each participant based on their  age, body weight 145 
and predicted aerobic capacity (Fujita et al. 1990). Expired gases were collected and analysed 146 
using a breath by breath analyser (Quark B2, Cosmed, Rome, Italy). The test was terminated 147 
when the subjects reached the 85% of their age-predicted maximal heart rate (220- age in 148 
years). All participants were able to reach this point of exertion. VO2max was then estimated 149 
by linear regression of the VO2 – heart rate relationship to the predicted maximal heart rate. 150 
During the test, particular attention was paid to the VCO2 and VE trends to verify that  Tvent 151 
was reached by every participant.  152 
 153 
Sub-Maximum Constant Load Tests and Fat-Max determination 154 
Each participant completed four 6-minute submaximal constant load treadmill 155 
exercise bouts, at intensities corresponding to 25%, 35%, 45% and 60% of their estimated 156 
VO2max, as determined from the incremental test (Achten et al. 2002; Ghanassia et al. 2006). 157 
 158 
Determination of training intensities 159 
‘Fat-max’ training intensity: For each participant, the intensity corresponding to the 160 
maximal rate of fat oxidation was calculated using the data obtained from the four 161 
submaximal constant load bouts, as described previously (Ghanassia et al. 2006; Venables et 162 
al. 2005). Briefly, data from the 5
th 
and 6
th 
minute of each bout were averaged and rate of 163 
lipid oxidation calculated from VO2 and VCO2 (Peronnet and Massicotte 1991). This was 164 
plotted against exercise intensity, and a third-order polynomial curve was fitted to the data 165 
(Stisen et al. 2006). The intensity at the maximal point of the resultant curve was identified, 166 
and the heart rate corresponding to this intensity was then used for prescription of the 167 
participant’s training zone. ‘Tvent’ training intensity: ventilatory threshold was identified 168 
from the incremental exercise test, using the modified V-slope method (Sue et al. 1988). Two 169 
experimenters calculated this point independently, and the average of the two VO2 values was 170 
used. Where the two VO2 values differed by more than 100ml, a second method was used to 171 
verify the VO2 corresponding to Tvent (method of ventilatory equivalents; (Noonan and Dean 172 
2000). 173 
Biochemical analysis 174 
Venous blood samples were obtained from an antecubital vein in heparin coated (for 175 
plasma acquisition) or clotting activator (for serum) Vacutainer
TM
 tubes using standard 176 
aseptic techniques. Samples were immediately centrifuged (at 4°C and 1000g for 15min), 177 
after which plasma or serum were removed and stored at −80°C for further analysis. 178 
Concentrations of glucose, total cholesterol and high-density lipoprotein cholesterol (HDL-C) 179 
were measured using a portable Cardiochek Analyser (Polymer Technology Systems, 180 
Indianapolis, Indiana, USA). Triglyceride (TG) concentration was quantified using a 181 
commercially available colorimetric assay (Tryglicerides Liquicolor, Wiebsbaden, Germany). 182 
Estimates of low-density lipoprotein cholesterol (LDL-C) concentration were calculated 183 
using the Friedewald formula (Friedewald et al. 1972). Glycosylated haemoglobin (% 184 
HbA1c) was assayed using DCA Vantage Serum Analyser (Siemens, Dublin, Ireland). 185 
Plasma glycerol was assessed using a colorimetric assay (Cayman Chemical Company, USA, 186 
Catalogue 10010755) according to manufacturer’s instructions. Highly sensitive, enzyme-187 
linked immunosorbent assay (EIA) methods were used to determine the concentration of 188 
leptin (Mercodia, Catalogue 10-1199-01, Uppsala, Sweeden) and adiponectin (Mercodia, 189 
Catalogue 10-1193-01) in plasma according to manufacturer’s instructions. Quantification 190 
was made using a microplate reader (Molecular Devices SpectraMax Plus 384, Sunnyvale, 191 
California, United States). Serum high-sensitivity C-reactive protein (hsCRP) was assayed 192 
using a CRP high sensitivity assay kit (Cayman, Ireland). Blood was centrifuged in heparin-193 
coated tubes and the red blood cell pellet homogenized in cold metaphosphoric acid. Redox 194 
state and glutathione metabolism was measured in erythrocytes by a modification of the 5,5'-195 
dithiobis(2-nitrobenzoic acid) [DTNB]/GSSG reductase recycling method, using the N-196 
ethylmaleimide conjugating technique for GSSG sample preparation (Krause et al. 2007). 197 
Total antioxidant activity was measured using a colorimetric assay (Catalogue No: 709001, 198 
Cayman, Ireland). Catalase activity was assessed using a Cayman Chemical Catalase Assay 199 
Kit (Catalogue No: 707002) and oxidative damage in proteins by using the Cayman 200 
Chemical’s Protein Carbonyl Colorimetric Assay Kit (catalogue 10005020) (Fayh et al. 201 
2012). Serum concentrations of IL-6 and TNF were quantified using a Human IL-6 and TNF-202 
alpha Quantikine ELISA Kit (Catalogue No: D6050 and DTA00C, R&D Systems, USA). 203 
The choice between plasma or serum samples for the analysis was based on the assay 204 
performed,  technique sensitivity and kit manufacturer instructions. Serum was used for IL-6, 205 
TNF-α and hsCRP; plasma for adiponectin, leptin, catalase, protein carbonyls, total 206 
antioxidant activity, triglycerides and glycerol and whole blood for glucose, LDL, HDL, 207 
HbA1c and total cholesterol measurements. 208 
 209 
Skeletal muscle microbiopsy and NOS protein expression 210 
Muscle biopsy samples were obtained using a spring-loaded and reusable instrument 211 
(Magnum reusable core biopsy instrument MG1522; Bard, Dublin, Ireland).  This technique 212 
has been assessed in terms of patient tolerance and causes minimal or no discomfort (Hayot 213 
et al. 2005). The muscle samples (~15 mg) were taken from the medial part of the vastus 214 
lateralis muscle under local anaesthesia (1% lidocaine). The samples obtained from each 215 
biopsy were immediately frozen in liquid nitrogen and stored at -80C until required. After 216 
removal from -80
o
C storage, tissue samples were thawed and homogenized in lysis buffer (20 217 
mM Tris-HCl, 5 mM EDTA, 10 mM Na-pyrophosphate, 100 mM NaF, 2 mM Na3VO4, 218 
10g/ml Aprotinin, 10 g/ml leupeptin, 3 mM benzamidine and 1 mM PMSF) using an 219 
automated homogenizer (TissueLyser LT, Qiagen, Dublin Ireland) . The homogenate was 220 
rotated at 4°C for 10 min, followed by centrifugation at 14,000g at 4°C for 10 min, after 221 
which the supernatant was collected. Cellular protein concentration was determined using a 222 
BCA protein Assay (Pierce, Rockford, IL, USA Catalogue No: 23225).  Protein samples 223 
(15g) were denatured in sample buffer and separated by 10% SDS PAGE. The proteins were 224 
transferred onto a nitrocellulose membrane (Amersham Biosciences, Ireland), blocked in 5% 225 
(BSA) and probed with the appropriate polyclonal antibodies; Anti-nNOS (1:10000 dilution, 226 
Cell Signalling Technologies, USA), Anti-iNOS (1:10000 dilution, Cell Signalling 227 
technologies, USA) and Anti-GAPDH (1:10000 dilution, Cell Signalling technologies, USA) 228 
over night. Following overnight incubation, membranes were washed and incubated for 60 229 
min at room temperature with horseradish peroxidase (HRP)-conjugated secondary 230 
antibodies (1:30000 dilution, Cell Signalling technologies, USA). The blots were washed and 231 
visualized with a horseradish peroxidase-based Supersignal West Pico chemiluminescent 232 
substrate (Pierce). Results of digitalized images were expressed as mean ± S.D. using anti-233 
GAPDH as an expression control. The densities of the bands were quantified using ImageJ 234 
version 1.44p (National Institutes of Health, USA).  235 
 236 
Nitric oxide product determinations (tNOx) in serum and skeletal muscle samples 237 
Frozen muscle samples were weighed, and homogenized in sterile PBS (phosphate 238 
buffer saline, GIBCO, Ireland) using an automated homogenizer (TissueLyser LT, Qiagen, 239 
Dublin Ireland). The homogenised tissue (and serum samples) were placed in an eppendorf 240 
tube and centrifuged at 10,000g for 20minutes. The supernatant was ultra-centrifuged using 241 
molecular weight cut-off filters (30kDa, Amicon, Millipore, Ireland) for 30 minutes at 242 
100,000g. The supernatant was used for the remainder of the assays. Nitric oxide levels were 243 
determined indirectly by quantification of their oxidised products of degradation, nitrates and 244 
nitrites, using nitrate reductase and the Greiss reagent technique by a colorimetric kit 245 
(Cayman Chemical Company, USA, Catalogue No: 780001). The inter-assay and intra-assay 246 
coefficients of variation for the Greiss reaction were 5.6% and 3.6% respectively. 247 
 248 
Statistical Analysis  249 
Data are presented as mean and SD. Ryan-Joiner normality test was applied prior to 250 
all analyses. For the following variables: glycaemia, HbA1c, insulin, HOMA-IR, HOMA-251 
beta, HDL, triglycerides, CRP, VO2max, TNF-α, IL-6, total antioxidants and glycerol, which 252 
were not-normally distributed, a logarithmic transformation was applied (Log10). An 253 
ANOVA General Linear Model (GLM) was performed to compare the four sub-groups with 254 
three factors of interaction: 1) the presence or not of T2D (Diabetes vs. Control); 2) Time 255 
(before and after exercise training); 3) exercise intensity (Fat-Max or Tvent).  Post-hoc Tukey 256 
test was further applied when appropriate. Finally, age, body fat percentage and estimated 257 
VO2max were added as co-variants in the ANOVA GLM. The alpha level was set at P<0.05. 258 
Data were analysed using Minitab 16 software.  259 
 260 
Results 261 
Adherence to Training 262 
 After the completion of the training, the data from the HR monitors were downloaded 263 
and individually analysed. Adherence to training was high (92%) with participants 264 
completing 447 of the prescribed 48 walking sessions. In addition, all participants were 265 
successful in training at the prescribed heart rate; the average difference between the 266 
prescribed and recorded training heart rate was small (-0.5 bpm). 267 
Comparison of the baseline blood biochemical variables between the obese control and 268 
the obese T2DM subjects 269 
As expected, glycaemia (5.20.4 vs. 8.361.2 mmol/L) and HbA1C (5.60.1 vs. 270 
7.30.9, % OR 381 mmol/mol vs. 562 mmol/mol) were higher in the T2DM group. 271 
Indicators of both insulin resistance (HOMA-IR) and beta-cell function (HOMA-) were 272 
altered in T2DM, indicating that diabetic participants were insulin resistant and also may 273 
present an abnormal beta-cell function. Total cholesterol and LDL cholesterol (139.733.8 274 
vs. 77.635.6 mg/dL) were lower in T2DM subjects. This was expected since the diabetic 275 
subjects were taking cholesterol-lowering statin drugs. VO2max was lower in T2DM than 276 
obese controls (31.26.45 vs. 38.95.27 ml.kg-1.min-1, P0.05). No differences were found 277 
between Control and T2DM for leptin, adiponectin, TNF- and total antioxidants. IL-6 was 278 
significantly higher in the T2DM group, although body fat percentage as a co-variant affected 279 
this result. Significant differences were found in protein carbonyls between control and 280 
T2DM individuals (75.541.6 vs. 141.752.1 nmol/mL respectively). In addition, reduced 281 
glutathione (GSH) was lower in diabetic patients (32.74.4 vs. 21.82.8, nmol/mL). 282 
 283 
Analysis of blood biochemistry parameters and body composition in response to 284 
exercise training 285 
General metabolic variables such as glycaemia, lipid metabolism and HbA1c are 286 
shown in Table 1. No differences were found between pre- and post-training in any of the 287 
training groups. Similarly, no changes were observed in adiponectin, leptin or TNF- (Table 288 
2). With the exception of IL-6, the co-variants (% body fat, age and VO2max) did not affect 289 
any other variable. Body composition, VO2max and blood pressure were also unchanged after 290 
the interventions.  291 
 292 
Antioxidants and oxidative protein damage in response to exercise training 293 
As shown in Table 2, the major differences regarding oxidative stress markers and 294 
antioxidants were related to the levels of protein carbonyls, being higher in T2DM subjects. 295 
Catalase activity increased in diabetic subjects only after Tvent training intervention, but not 296 
at Fat-Max (0.980.22 at basal levels vs. 1.960.3nmol/min/ml after Tvent training, Table 2). 297 
The diabetic subjects responded to exercise training with increased protein oxidative damage 298 
at both training intensities (Fat-Max and Tvent), as evidenced by decreased protein carbonyls, 299 
particularly in the Tvent group (147.252.6 at baseline and 66.5719.5nmol/ml after Tvent 300 
training intervention). There were no changes in markers of oxidative stress or protein 301 
damage in either control training group. No differences in glutathione metabolism were found 302 
between pre- and post-training samples (Table 2). However, baseline values for GSH were 303 
higher in the control group than in T2DM group and the difference remained after exercise 304 
training at both intensities. 305 
 306 
Serum levels of nitric oxide metabolites in response to exercise training 307 
Regarding serum tNOx, in all groups and intensities, no significant differences were 308 
found after the exercise training intervention (Table 2). On the other hand, baseline values for 309 
tNOx were higher in the control group than in T2DM group (18.682.78 vs. 310 
12.343.56mol/L,) and this difference remained following exercise training at both 311 
intensities.  312 
Skeletal Muscle iNOS/nNOS Expression and nitric oxide metabolites levels in response 313 
to exercise training 314 
We analysed the responses of iNOS/nNOS expression and the tNOx production in 315 
skeletal muscle samples to chronic (training) exercise (Figures 2A-D). Following training, the 316 
only significant change observed was an increase in the levels of nNOS and tNOx in the 317 
control group trained at Tvent intensity (Figure 2A). At basal levels, as expected, skeletal 318 
muscle nNOS was higher in controls than in diabetics and the opposite was found for iNOS 319 
expression levels, but this did not impact on the baseline tNOx levels between the groups 320 
(Figures 2A-D). 321 
 322 
Discussion 323 
The main finding of this study was that endurance exercise training, particularly at 324 
moderate intensity (Tvent), increased catalase activity and decreased protein oxidative 325 
damage in individuals who are obese with T2DM. However, this improvement was not 326 
accompanied by changes in glycaemia or body composition. These findings are in accordance 327 
with the observation that prescription of non-supervised physical activity alone does not 328 
improve glycaemic control in T2DM (Wisse et al. 2010). A further possible reason for not 329 
observing significant changes in variables such as HbA1c with exercise training is the regular 330 
use of anti-diabetic drugs which would improve many metabolic parameters and thus reduce 331 
the scope for further change. The exercise training program used in our intervention did not 332 
result in any detectable changes in nitric oxide production in obese T2DM subjects, although 333 
the levels of skeletal muscle nNOS expression and tNOx concentration were increased in the 334 
control obese group in response to moderate aerobic exercise training.  335 
Structured exercise is considered an important cornerstone for achieving good 336 
glycaemic control and reducing cardiovascular risk  in type 2 diabetes (O'Hagan et al. 2013; 337 
Praet and van Loon 2009) Several different protocols, intensities and types of exercise have 338 
previously been promoted for the diabetic population (for review, read (O'Hagan et al. 2013; 339 
Praet and van Loon 2009)). In the present study, we analysed the chronic effects of aerobic 340 
training under two different intensities, which was performed three times per week, with 341 
sessions lasting 30 minutes, for a period of 16 weeks.  342 
It was decided to compare Fat-Max vs. Tvent intensities because it has previously 343 
been suggested that low intensity protocols (which favour the use of fatty acids rather than 344 
carbohydrates as a source of energy) might improve metabolic, inflammatory and oxidative 345 
stress markers by inducing higher levels of fatty acid oxidation (Brun et al. 2007). This would 346 
be beneficial for T2DM subjects, since the disorder is associated with an earlier shift from fat 347 
to carbohydrate utilisation during exercise (Boon et al. 2007) and a reduced fat oxidative 348 
capacity (16; 17). It has been reported previously that a single bout of low intensity exercise, 349 
as opposed to high intensity exercise, substantially reduces the prevalence of hyperglycaemia 350 
throughout the subsequent 24h post-exercise period in longstanding T2DM patients [35]. In 351 
our hands, Fat-Max training did not change glycaemic or lipid profiles. Nevertheless, our 352 
findings do not exclude possible beneficial effects of this type of training for T2DM subjects, 353 
since we only evaluated fasting glycaemic values and not continuous daily variations, as 354 
described by Manders et al [35]. Furthermore, while significant training effects were not 355 
observed for most variables (glycaemia, lipid profile, HbA1c), calculation of Cohen’s effect 356 
sizes (results not shown) showed medium-to-large effects of training. Therefore it is possible 357 
that including larger group sizes might have resulted in a significant training effect.  358 
While NO· is an essential molecule for many physiological functions such as 359 
skeletal muscle glucose uptake and vasomotricity (Newsholme et al. 2009), its availability is 360 
decreased in diabetes. We aimed to analyse the nitric oxide production response of obese 361 
T2DM to exercise training. Our results indicated that exercise at Fat-Max or Tvent 362 
intensities, did not produce detectable change in NO· production within the T2DM groups. 363 
However, the control group that trained at Tvent intensity responded by increasing the 364 
production of tNOx and expression of nNOS. We have previously demonstrated that skeletal 365 
muscle nNOS and iNOS expression levels are different between healthy obese, T2DM obese 366 
and lean T2DM (Krause et al. 2012b). This may indicate that obesity, rather than diabetes 367 
alone is the cause of the differential levels of tNOx intracellularly (muscle) and 368 
extracellularly (serum). Increased circulating IL-6 may promote increased levels of iNOS 369 
within the skeletal muscle of the diabetic subjects (Krause et al. 2012a). The fact that T2DM 370 
subjects did not respond to the moderate intensity training (in contrast to controls) would 371 
suggest that their lack of response may be caused by the insulin resistant state itself, since 372 
cell-based insulin signalling is required for normal nNOS expression and nitric oxide 373 
production (Krause et al. 2012b; Newsholme et al. 2009). Despite the lack of change in nitric 374 
oxide production in our T2DM subjects, the possible beneficial effects of our exercise 375 
protocol on the cardiovascular system of these patients cannot be excluded. For instance, 376 
numerous interventions based on exercise and/or dietary changes have shown improved 377 
vascular responses, such as an increase in blood flow without any significant changes to nitric 378 
oxide production (Fayh et al. 2012; Monti et al. 2012). In addition, recent findings suggest 379 
that vasodilatory prostanoids are important in determining endothelial response to Ach in 380 
diabetic and non-diabetic subjects (Meeking et al. 2000). Thus increased prostaglandin-381 
mediated vasodilation may compensate for attenuated responses to NO·, as has been 382 
previously reported in diabetic subjects (Meeking et al. 2000).  383 
We have also confirmed that serum tNOx level (nitric oxide availability) is reduced 384 
in patients with diabetes. We speculate that this response is due to the reduced availability of 385 
circulating L-arginine (Newsholme et al. 2009; Newsholme et al. 2012). Decreased blood 386 
levels of insulin, increased angiotensin II, hyper-homocysteinaemia, increased ADMA 387 
(asymmetric ω-NG,NG-dimethylarginine), low plasma L-arginine and tetrahydrobiopterin 388 
(BH4) are all conditions likely to decrease NO∙ production and which are also associated with 389 
diabetes and cardiovascular disease (Newsholme et al. 2009). Recently, adipose tissue has 390 
been implicated in the regulation of vascular function in humans via the release of vasoactive 391 
cytokines called adipokines, including adiponectin and leptin (Antonopoulos et al. 2011). In 392 
our hands, however, no differences were found in theses adipokines after the exercise 393 
intervention and, for this reason, we cannot attribute the differences in nitric oxide to 394 
alterations in adiponectin levels.  395 
In insulin-resistant populations, several adipokines as well as muscle contraction-396 
induced factors, so-called myokines (i.e., IL-6), have been shown to modulate insulin 397 
resistance and inflammatory status (Pedersen and Febbraio 2008). Although there is a 398 
consensus that weight loss is associated with an increase in adiponectin and decreased levels 399 
of leptin, TNF-α  and high sensitivity C-reactive protein (hsCRP) (Madsen et al. 2008; 400 
Monzillo et al. 2003), studies on medium-term effects of exercise without concomitant 401 
weight loss are limited and produce somewhat inconsistent results (De Feyter et al. 2007; 402 
Lambert et al. 2008; Stewart et al. 2007). Indeed, we did not find any changes in adipokines 403 
(adiponectin and leptin), or cytokines (TNF-) following training irrespective of exercise 404 
intensity in any group, which may reflect the importance of weight loss and adiposity levels 405 
on the low-grade inflammation found in obesity and diabetes. On the other hand, IL-6 was 406 
higher in T2DM subjects. However, increments in IL-6 were correlated with greater body fat 407 
content in this group compared with the non-diabetic group. Thus higher concentrations of 408 
IL-6 in T2DM may be a consequence of greater body fat content, rather than diabetes itself. 409 
Free radicals (i.e. ROS and NO
.
), are known to be involved in the pathogenesis of 410 
diabetes (Brownlee 2001). Besides inhibiting intracellular insulin signalling, the 411 
aforementioned metabolic disturbances in glucose and fat metabolism increase the formation 412 
of Amadori-glycated proteins and advanced glycation end-products (AGE), which impair 413 
receptor function for AGE (RAGE) and enhance ROS levels in almost all organ systems 414 
(Brownlee 2001; Goldin et al. 2006). Chronic exposure to Amadori products, AGE and ROS 415 
can cause vasculopathy, glomerulopathy (Brownlee 2001; Vincent et al. 2007) and 416 
potentially also induce nerve cell damage (Vincent et al. 2007). In accordance, nutritional 417 
(Vincent et al. 2007) and/or exercise interventions (Ji 2002) that modulate AGE, RAGE 418 
and/or ROS formation have been reported to improve insulin sensitivity in experimental 419 
rodent models. Despite the fact that our exercise intervention did not induce changes in 420 
inflammatory profiles or body composition, T2DM patients who trained at Tvent improved 421 
their antioxidant defences (catalase), resulting in  lower oxidative damage, as represented by 422 
the levels of protein carbonyls. On the other hand, glutathione metabolism did not change, 423 
although at baseline levels, we demonstrated that diabetic subjects had lower levels of 424 
reduced glutathione. This may suggest that production of this antioxidant, perhaps as a 425 
consequence of decreased key amino acid availability for glutathione synthesis, was 426 
compromised, as previously suggested (Newsholme et al. 2012).  427 
 428 
Conclusions and Perspectives 429 
In summary, moderate-intensity exercise may promote alternative health benefits 430 
compared to exercise at Fat-Max intensities and, in the long term, may result in visible 431 
changes in glycemic control and cardiovascular improvement resulting in fewer diabetic 432 
complications. Obese, non-T2DM participants can respond to moderate intensity training by 433 
increasing nNOS levels and tNOx levels in skeletal muscle cells, which may represent an 434 
adaptative mechanism to exercise. However, NO related responses in T2DM patients did not 435 
respond in the same positive direction as observed for the control group, which may be 436 
attributable to their level of insulin resistance (unchanged after the exercise intervention). We 437 
suggest that it is important to evaluate other types of exercise, including different intensities 438 
and volumes of training in order to find the most appropriate exercise for obese and T2DM 439 
population to improve cellular and metabolic function. Despite the limitations of this study 440 
(absence of diet control and the small sample size), it is important to highlight that our 441 
intervention, in spite of the low training volume intervention, induced positive modifications 442 
among obese individuals with T2DM. 443 
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Tables and Figures Legends 595 
 596 
Table 1. Effects of exercise training on Subjects` Anthropometric, biochemical and 597 
physiological characteristics. 598 
 599 
Table 2. Effects of exercise training on Subjects` hormone, inflammatory and Oxidant/Anti-600 
oxidant profile. 601 
 602 
Figure 1. Study design. 603 
 604 
Figure 2. Representative Western blot of human skeletal muscle biopsies for nNOS/iNOS 605 
and intracellular tNOx. A: in Obese Control Subjects training at 60% VO2max intensity. B: in 606 
Obese Control Subjects training at 35% VO2max intensity. C: in T2DM Subjects training at 607 
60% VO2max intensity. D: in T2DM Subjects training at 35% VO2max intensity. Levels of 608 
nNOS and iNOS expression in the skeletal muscle of all subjects were measured. Total levels 609 
nitrites and nitrates (tNOx) were measured as an indication of nitric oxide production within 610 
the cells.   * P<0.05 when compared with baseline levels.  611 
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